Talis Biomedical Corp. (TLIS) PT Lowered to $0.40 at BTIG
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall St futures jump as Democrats sweep midterms
- What the Democratic sweep in the midterms means for markets
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
- UBS starts bullish coverage on Ferrari Group on luxury logistics growth
Tweet
Share
E-mailGet Alerts TLIS Hot Sheet
Price: $4.38 --0%
Rating Summary:
0 Buy, 1 Hold, 3 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 15 | Down: 20 | New: 12
Rating Summary:
0 Buy, 1 Hold, 3 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 15 | Down: 20 | New: 12
Join SI Premium – FREE
BTIG analyst Mark A. Massaro lowered the price target on Talis Biomedical Corp. (NASDAQ: TLIS) to $0.40 (from $0.50) while maintaining a Sell rating.
You May Also Be Interested In
- Amgen (AMGN) PT Raised to $398 at Truist Securities
- Gladstone Commercial (GOOD) PT Lowered to $11.50 at B.Riley
- Ventive Hospitality (VENTIVE:IN) PT Lowered to INR638 at Axis Capital Limited
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
